Is cerebrolysin available in the United States?

No. Cerebrolysin is not FDA-approved and is not legally marketed in the United States. It is approved and widely used in Europe, Asia, and Latin America for stroke, traumatic brain injury, and dementia. Some individuals import it for personal use, but this carries legal and quality risks.

Is there a risk of prion disease from cerebrolysin?

Cerebrolysin is derived from porcine (pig) brain tissue, which raises theoretical concerns about prion transmission. However, the manufacturing process includes extensive purification and heat treatment steps designed to inactivate prions. No cases of prion disease have ever been linked to cerebrolysin use in over 30 years of clinical use.

Content reviewed by clinical research staff

Last reviewed: March 2026Sources: PubMed, FDA, WADA Prohibited List

Evidence graded using the PeptideScholar A-D system

Cerebrolysin

BHuman Studies

Moderate Credibility

1 cited studyy · Evidence level B

Neuropeptide preparation (porcine brain-derived) · Brand: Cerebrolysin

Not FDA ApprovedPrescription Required

Cerebrolysin is a parenteral neuropeptide preparation produced from purified porcine brain proteins. It contains a mixture of low-molecular-weight peptides and free amino acids with neurotrophic activity. Approved for use in several countries for dementia and stroke recovery, though not FDA-approved.

Mechanism of Action

Contains neurotrophic factors including BDNF-like and CNTF-like peptides that promote neuronal survival, synaptic plasticity, and neurogenesis. Stimulates protein synthesis in neurons, reduces excitotoxicity, and inhibits amyloid aggregation. Also has anti-inflammatory and antioxidant properties in the CNS.

Benefits

Improves cognitive function in vascular dementia and Alzheimer's disease
May enhance recovery after acute ischemic stroke^[1]
Neuroprotective via multiple mechanisms (anti-apoptotic, anti-inflammatory)
Extensive clinical use outside the US with established safety profile

Not Medical Advice — Research-Reported Information Only

This content is for informational purposes only and does not constitute medical advice.

Cerebrolysin — Dosing in Published Research

Reported Routes: Intravenous, Intramuscular injection

Typically 10-30 mL IV or IM daily for 10-20 days, followed by maintenance dosing. Used in post-acute stroke, traumatic brain injury, and dementia protocols in Europe, Asia, and Latin America. Not available in the US.

The dosing information above is sourced from published research literature and clinical trials. These are not recommendations. Individual responses vary. Always consult a healthcare provider before considering any peptide-based therapy.

Side Effects

Dizziness and headache
Nausea and sweating
Injection site reactions
Rare allergic reactions (porcine-derived product)
Potential risk of prion transmission (theoretical; no cases reported)

Considering Peptide Research?

Cerebrolysin is not FDA-approved. Always consult a licensed healthcare provider before considering any peptide.

Use the Peptide Finder

Always Consult a Professional

Research & Evidence

ReviewCochrane Database Syst Rev, 2023

Cerebrolysin for acute ischaemic stroke.

Cochrane review found cerebrolysin may improve functional outcomes in acute ischemic stroke, but evidence quality was low to moderate; more rigorous trials needed

PMID: 37818733

References

1. Cerebrolysin for acute ischaemic stroke.. Cochrane Database Syst Rev, 2023. “Cochrane review found cerebrolysin may improve functional outcomes in acute ischemic stroke, but evidence quality was low to moderate; more rigorous trials needed” [PMID: 37818733]

Recommended Resources

The Peptide Protocols Handbook

Evidence-based reference guide covering mechanisms, research, and clinical applications.

View on Amazon

Third-Party Peptide Testing

Independent lab analysis to verify peptide purity and authenticity.

Learn More

Links may be affiliate links. See our disclosure.

Research Supplies

Equipment for responsible research-grade peptide handling and administration.

Alcohol Prep Pads (200 ct)

Sterile 70% isopropyl pads for injection site preparation — essential for subcutaneous protocols.

$5–10View on Amazon

1mL Insulin Syringes (28G)

Thin-gauge 28G syringes for subcutaneous peptide administration with minimal discomfort.

$10–18View on Amazon

Sharps Disposal Container (1 Qt)

Biohazard-safe sharps container for responsible disposal of used syringes.

$8–15View on Amazon

Digital Milligram Scale (0.001g)

High-precision scale for accurate measurement of peptide powder before reconstitution.

$20–40View on Amazon

Amazon affiliate links — we may earn a small commission at no extra cost to you. See our disclosure.

Cerebrolysin FAQ

Medical Disclaimer

This content is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations.

Always consult a qualified healthcare provider before starting, stopping, or modifying any treatment. Do not disregard professional medical advice based on information found on this site.

No claims of therapeutic efficacy are made for substances that are not FDA-approved for the discussed indications. Research citations reflect published findings and do not imply endorsement.

Related Peptides

Semax

Cognitive EnhancementNot Approved

Semax is a synthetic peptide derived from the ACTH(4-10) fragment, developed in ...

Evidence Level BView Details

Selank

Sleep & StressNot Approved

Selank is a synthetic peptide developed at the Institute of Molecular Genetics o...